Skip to content
Categories
Satellite Symposium

Recent updates on the management of locally advanced rectal cancer

- , Shanghai 3-4

Schedule Slot

Recent updates on the management of locally advanced rectal cancer

Categories
Satellite Symposium

Recent updates on the management of locally advanced rectal cancer

- , Shanghai 3-4

Endorsed by: GSK

  1. First Results From the AZUR-1 Trial on cCR with Dostarlimab Monotherapy in dMMR/MSI-H Locally Advanced Rectal Cancer (LARC)

    Presentation time:
    15 min
  2. The Management of Watch & Wait in locally advanced rectal cancer patients

    Presentation time:
    15 min